Showing results (41-50 of 65) with videos related to
Sort By:
Pageof 7
Analytical Chemistry|October 31, 2012
Practical and efficient strategy for evaluating oral absolute bioavailability with an intravenous microdose of a stable isotopically-labeled drug using a selected reaction monitoring mass spectrometry assayHao Jiang, Jianing Zeng, Wenying Li, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 26, 2013
A rugged and accurate liquid chromatography-tandem mass spectrometry method for the determination of asunaprevir, an NS3 protease inhibitor, in plasmaLong Yuan, Hao Jiang, Zheng Ouyang, et al.Analytical Chemistry|May 1, 2012
Calculation and mitigation of isotopic interferences in liquid chromatography-mass spectrometry/mass spectrometry assays and its application in supporting microdose absolute bioavailability studiesHuidong Gu, Jian Wang, Anne-Françoise Aubry, et al.Journal of Pharmaceutical and Biomedical Analysis|December 20, 2015
A highly sensitive and selective LC-MS/MS method to quantify asunaprevir, an HCV NS3 protease inhibitor, in human plasma in support of pharmacokinetic studiesHamza Kandoussi, Hao Jiang, Jianing Zeng, et al.Journal of Pharmaceutical and Biomedical Analysis|January 7, 2015
Sensitive and accurate liquid chromatography-tandem mass spectrometry methods for quantitative determination of a novel hepatitis C NS5B inhibitor BMS-791325 and its active metabolite in human plasma and urineHao Jiang, Roger Demers, Hamza Kandoussi, et al.Journal of Pharmaceutical and Biomedical Analysis|December 10, 2013
Improved liquid-liquid extraction with inter-well volume replacement dilution workflow and its application to quantify BMS-927711 in rat dried blood spots by UHPLC-MS/MSNaiyu Zheng, Jianing Zeng, Qin C Ji, et al.Journal of Immunological Methods|December 3, 2014
Development and characterization of a pre-treatment procedure to eliminate human monoclonal antibody therapeutic drug and matrix interference in cell-based functional neutralizing antibody assaysWeifeng Xu, Hao Jiang, Craig Titsch, et al.Bioanalysis|September 15, 2018
LC-MS/MS bioanalysis of plasma 1, 14-tetradecanedioic acid and 1, 16-hexadecanedioic acid as candidate biomarkers for organic anion-transporting polypeptide mediated drug-drug interactionsRasa Santockyte, Hamza Kandoussi, Weiqi Chen, et al.Analytical Chemistry|February 11, 2014
Innovative use of LC-MS/MS for simultaneous quantitation of neutralizing antibody, residual drug, and human immunoglobulin G in immunogenicity assay developmentHao Jiang, Weifeng Xu, Craig A Titsch, et al.Bioanalysis|November 19, 2016
UHPLC-MS/MS bioanalysis of urinary DHEA, cortisone and their hydroxylated metabolites as potential biomarkers for CYP3A-mediated drug-drug interactionsNaiyu Zheng, Lisa J Christopher, Xuewen Ma, et al.Pageof 7